Showing results (51-60 of 80) with videos related to
Sort By:
Pageof 8
The Journal of Investigative Dermatology|October 1, 2010
Expression of the stem cell markers nestin and CD133 on circulating melanoma cellsAlberto Fusi, Uta Reichelt, Antonia Busse, et al.International Journal of Cancer|October 10, 2009
Long term presence of a single predominant tyrosinase-specific T-cell clone associated with disease control in a patient with metastatic melanomaSebastian Ochsenreither, Alberto Fusi, Antonia Busse, et al.Journal of Translational Medicine|July 3, 2008
Relative quantification of TCR Vbeta-chain families by real time PCR for identification of clonal T-cell populationsSebastian Ochsenreither, Alberto Fusi, Antonia Busse, et al.Cancer Immunology, Immunotherapy : CII|September 8, 2011
Wilms' tumor protein 1 (WT1) peptide vaccination in AML patients: predominant TCR CDR3β sequence associated with remission in one patient is detectable in other vaccinated patientsSebastian Ochsenreither, Alberto Fusi, Anne Geikowski, et al.Cancer Immunology, Immunotherapy : CII|July 22, 2008
A prostate cancer vaccine comprising whole cells secreting IL-7, effective against subcutaneous challenge, requires local GM-CSF for intra-prostatic efficacyCaroline Schroten-Loef, Corrina M A de Ridder, Suzanne Reneman, et al.Journal of Translational Medicine|April 14, 2010
Comparison of T-cell receptor repertoire restriction in blood and tumor tissue of colorectal cancer patientsSebastian Ochsenreither, Alberto Fusi, Susanne Wojtke, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 15, 2010
"Wilms Tumor Protein 1" (WT1) peptide vaccination-induced complete remission in a patient with acute myeloid leukemia is accompanied by the emergence of a predominant T-cell clone both in blood and bone marrowSebastian Ochsenreither, Alberto Fusi, Antonia Busse, et al.Clinical & Experimental Metastasis|March 23, 2013
Characterization of small spheres derived from various solid tumor cell lines: are they suitable targets for T cells?Antonia Busse, Anne Letsch, Alberto Fusi, et al.Tumori|July 5, 2003
Current treatments of neuroendocrine tumors role of biotherapy and chemotherapySilvia Della Torre, Giuseppe Procopio, Alberto Fusi, et al.Cancer Immunology, Immunotherapy : CII|May 10, 2011
Increased PRAME antigen-specific killing of malignant cell lines by low avidity CTL clones, following treatment with 5-Aza-2'-DeoxycytidineMengyong Yan, Nourredine Himoudi, B Piku Basu, et al.Pageof 8